Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

scientific article

Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P6179Dimensions Publication ID1032013510
P356DOI10.1186/1741-7015-11-183
P932PMC publication ID3826871
P698PubMed publication ID23945332
P5875ResearchGate publication ID255954826

P2093author name stringJun-Ichi Kira
P2860cites workEfficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trialQ34941384
Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trialQ35065987
Global epidemiology of HTLV-I infection and associated diseasesQ36254899
Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathyQ36981737
Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction studyQ39138593
Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLsQ39149901
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesisQ39291807
Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.Q39305599
Safety of long-term treatment of HAM/TSP patients with valproic acidQ39321719
Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous systemQ39541717
Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological studyQ39611506
Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cellsQ42071070
Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathyQ45087228
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis.Q55239353
Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I-associated myelopathy.Q55242452
P407language of work or nameEnglishQ1860
P921main subjectvitamin BQ183206
thiamine(1+) ionQ83187
paraparesisQ3363589
Human T-lymphotropic virus 1Q1280388
spastic paraparesisQ55083510
P304page(s)183
P577publication date2013-08-15
P1433published inBMC MedicineQ4835947
P1476titleTherapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
P478volume11

Reverse relations

cites work (P2860)
Q38972538Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon
Q36157642Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tr
Q38878420Update on Neurological Manifestations of HTLV-1 Infection

Search more.